Status:
UNKNOWN
A Morbidity-Mortality and Remodeling Study With Valsartan
Lead Sponsor:
Jikei University School of Medicine
Conditions:
Hypertension
Ischemic Heart Disease
Eligibility:
All Genders
20-79 years
Phase:
PHASE4
Brief Summary
The JIKEI HEART Study has been designed to investigate whether concomitant treatment with valsartan, an angiotensin II receptor blocker (ARB), in addition to conventional treatment, will improve the p...
Detailed Description
Several recent clinical trials have demonstrated that angiotensin II receptor blockers (ARBs) have cardiovascular as well as renal protective effects. However, it is a problem that the number of Asian...
Eligibility Criteria
Inclusion
- Clinical diagnosis of hypertension, ischemic heart disease and congestive heart failure
Exclusion
- Pregnancy
- Severe renal damage
- Severe liver damage
- Acute myocardial infarction
Key Trial Info
Start Date :
January 1 2002
Trial Type :
INTERVENTIONAL
End Date :
November 1 2005
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT00133328
Start Date
January 1 2002
End Date
November 1 2005
Last Update
October 28 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Jikei University School of Medicine
Tokyo, Japan, 105-8461